What FHIR Implementation ‘Done’ Actually Looks Like: Milestones, Metrics, and Go-Live Confidence
Healthcare organizations invest significant time and resources in FHIR implementations only to find that ‘done’ is harder to define than expected. API connectivity is a milestone, not a completion. Data validation is a milestone, not a completion. The question of what actually constitutes a production-ready, clinically valuable FHIR implementation is one that most project sponsors cannot answer precisely before the project begins—and that ambiguity costs money and momentum. This article defines what done looks like, milestone by milestone, with measurable criteria that project sponsors can use to track progress and make go-live decisions with confidence.
The Milestone Framework
| Phase Gate | What Must Be True | Who Signs Off |
| Discovery complete | Clinical use case defined; workflow map validated; EHR API tested; data quality baseline established | CMIO / Clinical Lead + CIO |
| Architecture approved | FHIR server selected; resource profiles drafted; terminology service configured; integration topology documented | Architecture Review Board |
| Integration build complete | All required resource types returning data; profile validation passing; terminology mapping complete | Integration Lead + Data Quality Owner |
| Clinical acceptance | Clinical stakeholders have validated data appearance and accuracy in workflow context; edge cases tested | Clinical Champion + CMIO |
| Go-live criteria met | All five go-live confidence criteria met (see below) | CIO + Clinical Lead + Project Sponsor |
| Operational handoff | Monitoring dashboards active; support processes documented; operational owner identified and trained | Operations Lead + IT Leadership |
The Five Go-Live Confidence Criteria
Clinovera uses five binary criteria to determine whether a FHIR implementation is ready for production go-live. All five must be met. Partial credit does not constitute readiness.
Criterion 1: Data Completeness
Greater than 95% of expected FHIR resources are present and populated with must-have elements as defined in the resource profiles for the clinical use case. Measurement: automated profile validation against a representative sample of the patient population in the test environment.
Criterion 2: Coding Accuracy
Greater than 90% of coded values in clinical resources are mapped to standard terminologies as required by U.S. Core profiles and organizational profiles. Measurement: terminology service validation reports for each resource type in scope.
Criterion 3: EHR Connectivity Stability
Zero critical connectivity failures (complete API unavailability or systematic data corruption) in the 7 days preceding go-live in the testing environment. Measurement: API monitoring dashboard with defined SLA thresholds.
Criterion 4: Clinical Workflow Validation
All workflow touchpoints identified during discovery have been validated by clinical stakeholders and accepted without outstanding critical issues. Minor issues with documented remediation plans are acceptable. Measurement: clinical acceptance testing sign-off document with issue log.
Criterion 5: Operational Readiness
Monitoring dashboards are deployed and active, support escalation paths are documented and tested, on-call contacts for the first 30 days post-go-live are confirmed, and the operational team has completed a go-live dry run. Measurement: operational readiness checklist completed and signed off.
Data Validation Benchmarks by Resource Type
| FHIR Resource | Completeness Threshold | Coding Accuracy Threshold | Key Validation Checks |
| Patient | 99% | N/A (identity data) | MRN present, name structured, DOB populated, address present |
| Observation (Lab) | 95% | 98% LOINC-coded | Value present, reference range present, status final/amended, effective date populated |
| MedicationRequest | 92% | 95% RxNorm-coded | Medication coded, status active/completed, authored date present, prescriber referenced |
| Condition | 90% | 90% ICD-10/SNOMED-coded | Code present, clinical status present, onset date populated where available |
| Encounter | 98% | N/A (encounter type) | Status present, class present, period start populated, participant referenced |
| AllergyIntolerance | 88% | 85% SNOMED-coded | Substance coded or text present, criticality present, verification status present |
Post-Go-Live Support: The 30-60-90 Day Framework
Go-live is not the end of the implementation. The 30 to 90 days following go-live are when real-world data quality issues surface, clinical adoption patterns become visible, and the system either builds or loses clinical trust. Post-go-live support structured around defined checkpoints is the difference between an implementation that stabilizes and one that quietly degrades.
- Day 30: Data quality review against go-live benchmarks. Any resource type below threshold triggers root cause analysis and remediation plan.
- Day 30: Clinical adoption review. Utilization metrics reviewed with clinical champion. Workflow friction reported and triaged.
- Day 60: Operational stability review. Support ticket volume and resolution time reviewed. Monitoring threshold adjustments based on production patterns.
- Day 90: Full post-go-live assessment. Outcomes measurement against clinical success metrics defined before go-live. Scope expansion recommendations.
What Success Metrics Should Look Like
Success metrics for FHIR implementations should be expressed in clinical and operational terms, not just technical terms. Technical metrics (API uptime, message volume) are necessary for operational monitoring but insufficient for demonstrating clinical value to executive sponsors and project stakeholders.
| Use Case | Technical Metric | Clinical/Operational Metric |
| Care transitions | API call volume, resource availability rate | Medication reconciliation time at transitions, adverse drug event rate |
| Patient Access API | API uptime, query response time | Patient app connection rate, patient satisfaction with data access |
| Prior authorization | PA transaction volume, API error rate | Prior authorization cycle time, denial rate, staff time per PA |
| Care gap closure | Care gap data refresh frequency | Care gap closure rate, outreach contact rate |
| Population health analytics | Bulk export completion rate, data freshness | Quality measure reporting accuracy, registry completeness |
FAQ
What if we cannot meet all five go-live criteria by the compliance deadline?
This is a real scenario that requires an explicit risk conversation with executive leadership. Clinovera recommends going live on the compliance deadline with a documented exception for any unmet criteria, a defined remediation timeline, and active monitoring in place to detect issues before they create clinical harm. Going live with known gaps is not ideal, but going live with unknown gaps—because the criteria were not defined—is more dangerous.
Who should own post-go-live data quality monitoring?
Data quality monitoring requires a named owner with the authority to escalate issues to source system owners and clinical informatics leadership. In most organizations, this responsibility sits with the clinical informatics or health informatics function. IT operations can own technical monitoring (API availability, error rates), but clinical data quality requires clinical informatics ownership.
How do we communicate go-live readiness to the board or executive leadership?
The five go-live confidence criteria provide a straightforward executive readiness report: which criteria are met, which are not, what the remediation plan is, and what the go-live timeline is based on current progress. A single-page readiness dashboard updated weekly during the final 4 weeks before go-live gives executive sponsors the visibility they need without requiring detailed technical knowledge.
Defining Done Before You Start
The most valuable thing any FHIR implementation can do before the first line of code is written is to define what done looks like. Clinovera’s engagement kickoffs always include a go-live readiness workshop that aligns technical leads, clinical stakeholders, and project sponsors on the criteria that will be used to make the go-live decision. Starting with that alignment reduces the risk of scope ambiguity, clinical adoption failure, and the expensive rework that follows.
Contact Clinovera to discuss how the go-live readiness framework would be structured for your implementation.